Search This Blog

Tuesday, September 29, 2015

Amgen To Present New Kyprolis® (carfilzomib) Data At 15th International Myeloma Workshop Additional Data From Phase 3 ASPIRE Trial Including Age Analysis and Quality of Life Results

Amgen - Investors - RSS Content

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.